Ehave, Inc. Subsidiary MDLink growing at a tremendous pace opening opportunities for platformMIAMI, Fla., June 15, 2020 (GLOBE NEWSWIRE) --...
SINGAPORE - Media OutReach - 15 June 2020 - With more than 20 years' media intelligence leadership and expertise, Australian businessman John...
Findings from the report reveal 75% organizations require increased infrastructure budget for new tools, technologies and collaborative networks to navigate...
KUALA LUMPUR, MALAYSIA - Media OutReach - 15 June 2020 - As Malaysia slowly emerges from the enforced lockdown period and into...
Survey shows nearly three-fourths fear a second lockdown; Revenue and M&A interest dip amid uncertainty heading into H2 2020VANCOUVER, British...
HANOI, Vietnam--(BUSINESS WIRE)--FPT, Vietnam’s largest IT service provider, has signed a strategic partnership agreement with Quebec-based research centre Mila in...
− These Data Demonstrate Breadth of Takeda’s Portfolio and Pipeline with Three Hematology Presentations at the Virtual Summit OSAKA, Japan--(BUSINESS...
- The primary endpoint (antitumor effect) was achieved - No new safety concerns were identified in the safety analysis - This study was...
TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it will end the production of TFT-LCD modules manufactured by its...
VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical Limited ACN 058 466 523 (Company) is pleased to announce that shareholders today...
Tapped as BORN’s exclusive PIM partner, Akeneo’s Product Experience Management (PXM) capabilities well complement BORN’s award-winning digital omnichannel enterprise commerce...
HONG KONG--(BUSINESS WIRE)--Recently, FPS+Roguelite game Gunfire Reborn developed by Duoyi (Hong Kong) Interactive starts Early Access on Steam. Upon release,...
Devart rolled out the updated versions of dbExpress drivers with support for the newly released RAD Studio 10.4 Sydney. Prague,...
Data from a Phase II trial show a regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) was well tolerated...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX: BRN), a leading provider of Ultra-Low Power, high performance AI technology, today announced...
